FDA NDC Directory · JSON-LD · Markdown

GLASSIA

NDC 0944-2884 · PLASMA DERIVATIVE · INJECTION, SOLUTION

Generic nameALPHA.1-PROTEINASE INHIBITOR HUMAN
Labeler / ManufacturerTakeda Pharmaceuticals America, Inc.
Marketing categoryBiologic License Application · App BLA125325
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS
Active ingredients.ALPHA.1-PROTEINASE INHIBITOR HUMAN (1 g/50mL)
Marketing started20100701
Package count3

External sources

Source: openFDA. Public-domain (CC0).